PFAS: why the forever chemicals are also a hormone topic
They are measurable in the blood of almost every person. They stay for years rather than hours. And the European limit value for them rests on an endpoint that hardly anyone has on their radar. What of that concerns your menstrual cycle, and what does not.
PFAS are the reason I also ask about the environment when hormonal complaints are on the table. They stay in the body for years, they are measurable in almost everyone, and their effect on the immune response of children is so well studied that a European authority built its limit value on it. At the same time the data on menstrual cycle, menopause and endometriosis are considerably weaker, and I say that just as plainly.
You are standing in the kitchen turning the pan into the light. A fine scratch, right across the base. Yesterday the radio said something about forever chemicals, today it is in your news feed, and someone in the comments has written that they wreck your hormones.
You put the pan back. Then your eye falls on the rain jacket in the hallway. On the baking paper in the drawer. On the water bottle.
Many women know this pattern. It starts with a headline and ends with half the kitchen looking suspicious. And usually the actual question never gets asked: what of this concerns me, and on what scale.
So I am not starting with the pan. I am starting with a number that sorts everything else: with the time these substances stay inside you.
What is waiting for you here
- Why the carbon-fluorine bond makes this group of substances so unusual
- Half-lives from months to years, with the concrete numbers
- Where PFAS really come from, in the order the data support
- The EFSA assessment of 2020 and the endpoint behind it
- All hormonal endpoints, sorted by strength of evidence
- The reasoning error about menopause that almost every text repeats
- When a blood measurement makes sense and when it only weighs on you
- Filters, pans, baking paper: what realistically changes something
- Blood donation and bloodletting, honestly placed
- Where avoidance ends and why that is no reason to feel powerless
One note up front, because it stands above the whole text. Every single statement here carries a label saying which kind of study it comes from. Cell culture, animal model, observation in humans, or intervention in humans. In environmental medicine this distinction is exactly what separates a serious text from one that frightens you.
Independently of any environmental question, these signs belong in a timely medical examination and should not be waited out:
- any bleeding after menopause
- very heavy or suddenly markedly changed bleeding
- acute one-sided lower abdominal pain
- pain together with fever
- unintended weight loss
- headaches or visual disturbances together with milk discharge from the breast
- rapidly increasing signs of virilisation such as a deepening voice or strong facial hair growth
This list has nothing to do with PFAS. It stands right at the front deliberately, because an environmental article must never be the reason to wait with something like this. The gynaecological work-up remains the foundation. The environmental question comes on top of it, not in its place.
What PFAS are, and why forever chemicals is not a marketing word
The word sounds like an exaggeration. Like a term invented by a campaign because it shares well.
It is not. It is a chemical description.
PFAS stands for per- and polyfluoroalkyl substances. Picture a short chain of carbon atoms, like a string of beads. Normally there is hydrogen attached to every bead. In PFAS this hydrogen has been replaced by fluorine, partly or completely.
That one change makes the whole difference. Fluorine is the most electronegative element there is. It holds on to its binding partners like hardly any other atom. The carbon-fluorine bond is one of the strongest single bonds in organic chemistry.
In practical terms: sunlight does not get through it. Soil bacteria do not either. And the enzymes of your liver, which otherwise take apart almost anything foreign, find no point of attack here.
The result is a material that repels water, repels grease and repels dirt. That is exactly why it is everywhere: in coatings, in impregnations, in packaging, in firefighting foam, in thousands of industrial applications.
How large the group of substances is depends on where the definition is drawn. The European Food Safety Authority speaks of a very large group in its 2020 assessment. Figures circulating publicly range from several thousand to more than ten thousand compounds, depending on the boundary. I give the range because I cannot document the one fixed number.
With most environmental substances the question is: how toxic is a molecule? With PFAS the decisive question is a different one: how long does it stay?
Bisphenol A and most plasticisers are not harmless per molecule, but your body is rid of them within hours to a few days. If you switch off the source, the value falls quickly. With PFAS that logic does not apply. Here what comes in accumulates, and it leaves again over years.
That changes everything: the meaning of a single contact, the point of a measurement, and the question of whether avoidance can change anything at all. Yes, it can. But on a different time axis than you expect.
What an endocrine disruptor actually is and how these substances dock onto receptors I have described in detail in the overview of xenoestrogens in everyday life. Here I take that as read and look only at what sets PFAS apart from all the others.
A second difference belongs right here, because it is regularly misrepresented in consumer texts. PFAS are not broken down through the classic detoxification pathways of the liver. There is no phase 1 step that cracks them open and no phase 2 step that makes them water soluble. They bind to proteins in the blood, are filtered in the kidney and to a large extent brought back there, and they run the same loop several times through the circuit between liver and gut. How these phases normally work is described in the article on phase 1 and phase 2 of detoxification. With PFAS this model simply does not apply.
The Endocrine Society, the largest hormone medicine society in the world, published its second scientific statement on endocrine disrupting chemicals in 2015. A team of authors reviewed mechanistic, animal and human data across seven topic areas.
The authors state that the research of the preceding five years had substantially better documented three things: non-monotonic dose-response relationships, effects in the low dose range, and the particular vulnerability of developmental windows.
For you that means: the rule of thumb that more harms more does not hold reliably for endocrine disruptors. A low blood value is not a free pass, and the timing of an exposure can matter more than its amount.
Gore AC, Chappell VA, Fenton SE et al. Endocr Rev. 2015;36(6):593-602. PMID: 26414233 · DOI: 10.1210/er.2015-1093 [Consensus Guideline] [Guideline]And now you know why with these substances the clock is the more important measure than the scales.
How long PFAS stay in the body, and what that means for you
Picture a bathtub. Water runs in at the top, and there is a drain at the bottom.
With most environmental substances the drain is wide open. You turn off the tap and the tub is empty the next day. With PFAS the drain is a bottleneck. You turn off the tap and the tub needs years.
That number is not known from the laboratory but from a tragic natural experiment.
In the Swedish town of Ronneby a third of households had been supplied for decades with drinking water contaminated with PFAS from firefighting foam used at the neighbouring airfield. On 16 December 2013 the supply was switched over. A research team then took up to ten blood samples from 114 people aged 4 to 84 years between 2014 and 2018.
The mean estimated serum half-lives were 0.94 years for PFPeS, 2.47 years for PFOA, 2.73 years for linear PFOS, 4.52 years for PFHxS, 4.55 years for PFHpS and 5.01 years for a branched form of PFOS. Shorter half-lives were found with younger age, better kidney function and in women of fertile age between 15 and 50 years.
For you that means: anyone who switches off the source today needs years, not weeks. And the observation that women of fertile age excrete faster is not a side note. It carries the most important part of this article later on.
Li Y, Andersson A, Xu Y et al. Environ Int. 2022;163:107198. PMID: 35447437 · DOI: 10.1016/j.envint.2022.107198 [Cohort, human]The second large study on this comes from the USA and delivers the same order of magnitude by a completely different route.
Two heavily exposed water districts in Ohio and West Virginia began granular activated carbon filtration in 2007. A team around Bartell then took up to six blood samples per person from a total of 200 participants between May 2007 and August 2008.
Among customers of one of the two districts who mainly drank tap water, serum PFOA fell on average by 32 ng/mL, that is by 26 percent. The covariate adjusted mean rate of decline was 26 percent per year, consistent with a median serum half-life of 2.3 years.
For you that means: effective filtration at the source lowers blood values measurably. But slowly. That is the realistic frame of expectation for everything you change yourself.
Bartell SM, Calafat AM, Lyu C et al. Environ Health Perspect. 2010;118(2):222-228. PMID: 20123620 · DOI: 10.1289/ehp.0901252 [Cohort, human]A third, very small study supports the same order of magnitude. In the Tama region west of Tokyo the drinking water source had been changed in 2019. In 17 participants aged between 53 and 83 years the estimated half-lives, after subtracting Japanese background values, were 2.7 years for PFOS, 5.6 years for PFHxS and 5.1 years for PFOA. With only 17 people that is not proof but an indication. Still, the order of magnitude of years turns up again in another country. Lyu Z, Harada KH, Sugii Y et al. Environ Health Prev Med. 2026;31:3. PMID: 41548900 · DOI: 10.1265/ehpm.25-00330 [Cohort, small, human]
Not all PFAS behave the same. The German Environment Agency sums it up like this: short-chain compounds leave the body within a few days to about a month, long-chain ones take several years. The industry switch to short-chain replacements is therefore, seen from the residence time in humans, a step forward. For the environment that does not hold, because there they are practically not degraded either.
Menstruation, pregnancy and breastfeeding are elimination routes for PFAS. Blood, placenta and breast milk carry these substances out of the body.
That is physiology first of all. It explains why women of fertile age had shorter half-lives in the Ronneby cohort and why in the southern German study the medians in women were somewhat lower than in men.
Remember this paragraph. It is the key to the section on menopause and menstrual cycle, and it is the reason why half the headlines on this topic get the direction of cause and effect the wrong way round.
And now you know why with PFAS I do not talk about single contacts but about years.
Where PFAS really come from, in the honest order
If someone asks you about PFAS, you think of the pan. Almost everyone does.
But the pan is not the quantity. It is the symbol.
In 2020 the European Food Safety Authority assessed what people in Europe actually take up PFAS through. The result: food and drinking water contribute the most. As the main contributing food groups across all population groups the authority names fish meat, fruit and fruit products, and eggs and egg products.
That is uncomfortable, because it shifts the room for action to where you have the least influence. That is exactly why it stands here first and not at the end.
Drinking water and food
Drinking water is the route through which exposure varies most strongly by location. We owe both large cohorts in this field to contaminated drinking water, Ronneby and the mid Ohio valley. With food the distribution is more diffuse. For the combined exposure to PFOA, PFNA, PFHxS and PFOS, EFSA names three contributing groups: fish meat, fruit and fruit products, and eggs and egg products. That fruit is among them surprises many, and that is exactly why I name it. The simple formula that animal foods carry the load and plant foods are clean does not hold for this group of substances.
Why we still do not recommend fish
In my practice I do not recommend fish at all, not even small fish. The reason for that is not PFAS, though, it is mercury. That is an independent practice position and not a deduction from the PFAS data. I write this out explicitly so that no impression arises that I am retrospectively justifying my position with a currently topical subject.
The context on mercury is under mercury and elimination, and the question of measurement under measuring heavy metals in blood or urine. Omega-3 can be covered through an EPA preparation or through algae oil. The suitable amount depends on your values and therefore belongs in a consultation.
Packaging, paper and coatings
A research team examined around 400 samples of food contact papers, paperboard containers and beverage cups from fast food restaurants in the USA. Total fluorine content was measured first, and for 20 samples additionally with high resolution mass spectrometry.
46 percent of the food contact papers and 20 percent of the paperboard samples contained detectable fluorine. In the more closely examined subgroup, perfluorocarboxylates, perfluorosulfonates and further polyfluorinated compounds were found, some of them unidentified.
For you that means: grease repellent paper is a real contributing route, not scaremongering. And the label PFOA free says nothing about the remaining substances in the group.
Schaider LA, Balan SA, Blum A et al. Environ Sci Technol Lett. 2017;4(3):105-111. PMID: 30148183 · DOI: 10.1021/acs.estlett.6b00435 [Real-World, product analysis]The limitation that belongs with it: those were US samples from 2014 and 2015. I am not aware of a comparable German market survey. The European legal framework for food contact materials is a different one.
With non-stick coatings the situation is more nuanced than the headlines suggest. The coating is a polymer, that is a very large molecule, considered largely unreactive while intact. The figures circulating about millions of particles per scratch come from work on microplastics and not on PFAS uptake in humans. I did not find a robust human study on this. That is a gap, not an all clear.
Textiles, furniture, cosmetics, firefighting foam
Impregnated outdoor clothing, water repellent furniture covers, individual cosmetic products and above all firefighting foam belong here too. Firefighting foam is historically the most important cause of local drinking water contamination, because it went into the ground directly and in large quantities. That is why people living near airfields and fire service sites turn up in almost all exposure cohorts.
How high is exposure in Germany
For the fifth German Environmental Survey on health, twelve PFAS were measured in 1,109 blood plasma samples from children and adolescents between 3 and 17 years, population representative.
PFOS was quantifiable in all samples, PFOA in almost all. The highest geometric means were 2.49 ng/mL for PFOS, 1.12 ng/mL for PFOA and 0.36 ng/mL for PFHxS. The 95th percentiles were 6.00 ng/mL for PFOS and 3.24 ng/mL for PFOA. The authors speak of a still considerable exposure of the young generation to PFOS and PFOA, substances that were phased out long ago.
For you that means: if you have PFAS in your blood, you are not a special case. Almost every child in Germany has them too.
Duffek A, Conrad A, Kolossa-Gehring M et al. Int J Hyg Environ Health. 2020;228:113549. PMID: 32502942 · DOI: 10.1016/j.ijheh.2020.113549 [Cohort, biomonitoring]In southern Germany the place of residence barely differed
969 blood samples from three regions with known PFAS releases into the environment and from three control regions were examined for nine environmentally relevant PFAS. The expectation was that the regions would differ clearly.
The medians were 0.8 to 0.9 ng/mL for PFOA and 1.3 to 1.5 ng/mL for PFOS, in study regions as well as control regions, all below the HBM-I values. Between the regions only small differences were found. In women the medians for PFOS and PFOA were slightly lower than in men.
I name this result because it contradicted my own assumption. Living in a region with documented releases is apparently not a good indicator of your own blood value. And the somewhat lower values in women are not a sign of better protection but a pointer to the elimination routes.
Hron LMC, Wöckner M, Fuchs V et al. Arch Toxicol. 2024;98(11):3727-3738. PMID: 39167139 · DOI: 10.1007/s00204-024-03843-x [Cohort, biomonitoring]And now you know why the honest order starts with the water glass and not with the pan.
The EFSA assessment of 2020, and why of all things the vaccine response counts
When an authority sets a limit value, it has to decide on an endpoint. On the one effect that becomes measurable at the lowest exposure.
With PFAS you might have expected cancer. Or the liver. Or hormones.
It turned out to be something else: the antibody response of children after vaccinations.
In 2020 the CONTAM Panel of the European Food Safety Authority reviewed the entire body of data on PFAS in food and derived a health based guidance value from it.
The result is a group TWI of 4.4 nanograms per kilogram of body weight per week for the sum of PFOA, PFNA, PFHxS and PFOS. The critical endpoint was the reduced antibody response after vaccinations in children, derived via diphtheria titres in one year olds and a pharmacokinetic model. The authority states that parts of the European population exceed this intake level and that this is relevant to health.
For you that means: the European limit value for PFAS does not rest on cancer data and not on hormone data. It rests on the immune system of children. That explains why this group of substances is taken so seriously by regulators.
Schrenk D, Bignami M, Bodin L et al. (EFSA CONTAM Panel). EFSA Journal 2020;18(9). DOI: 10.2903/j.efsa.2020.6223 [Regulatory Document] [Guideline]This is not an argument against vaccination. The vaccine response is a measuring instrument here, not a matter of dispute. You vaccinate a child, measure the antibody level later, and have a cleanly quantifiable piece of information about how well its immune system answers a defined stimulus. Hardly any other route measures immune function in humans in such a standardised way.
So the finding is not that vaccinations are a problem. It is that a higher PFAS exposure goes along with a somewhat weaker answer to the same stimulus.
A systematic review with multilevel meta-regression pooled 14 reports from the years 2012 to 2022, from 13 different study populations. What was examined was the change in the logarithmised antibody level per doubling of the PFAS serum concentration.
For PFOA in children across all antibodies the change was -0.10 (95 percent confidence interval -0.16 to -0.03), for diphtheria in children -0.12 (-0.23 to -0.00) with a rating of high certainty. For PFOS and rubella in children -0.12 (-0.20 to -0.04), also high certainty. For PFNA and PFDA no statistically supported association could be shown.
For you that means: this is the best documented health endpoint for PFAS at all. And the effect per doubling is small. Both belong in the same sentence, otherwise the text becomes dishonest, in whichever direction.
Crawford L, Halperin SA, Dzierlenga MW et al. Environ Int. 2023;172:107734. PMID: 36764183 · DOI: 10.1016/j.envint.2023.107734 [Meta-analysis]In the American health survey NHANES the same pattern showed up in 12 to 19 year olds: in seropositive children a doubling of PFOS went along with a 13.3 percent lower rubella antibody concentration (-19.9 to -6.2). For current allergic conditions including asthma, by contrast, no unfavourable association was found. The finding is therefore directed at the vaccine response and not at allergies. Stein CR, McGovern KJ, Pajak AM et al. Pediatr Res. 2016;79(2):348-357. PMID: 26492286 · DOI: 10.1038/pr.2015.213 [Cohort, cross-sectional]
A literature review of 42 human studies since 2010 sorts the gradation within the same organ system: strong indication of a reduced vaccine antibody response, some indication of increased infection risks, and only limited indications for allergy, atopic dermatitis and asthma.
An authority does not decide because everything is proven
The EFSA derivation is conservative. It rests on an endpoint whose clinical meaning for the individual child is unclear. A diphtheria titre that is ten percent lower does not mean that a child falls ill. It means that its immune system answers the same stimulus measurably more quietly.
This derivation is discussed among experts, and that is legitimate. Authorities decide under uncertainty. They do not wait until everything is proven, because with a substance that has a half-life of years that would be too late. That is precisely the core of the precautionary principle, and you can argue about it without being unserious.
My position: a substance that shifts such a soft and well measurable endpoint consistently in a meta-analysis is doing something biologically. Immune response and hormonal axes are not separate systems. They share messengers, receptors and regulatory loops. That is why this section stands in an article about hormones.
And now you know why I do not treat PFAS as a marginal topic even though the hormonal data are thinner than the immunological ones.
The hormonal endpoints, cleanly sorted by strength of evidence
This is where serious and unserious texts on this topic part ways.
Online the endpoints usually stand side by side as if they were equally well documented. Vaccine response, cholesterol, thyroid, fertility, endometriosis, PCOS, all in one list. That is convenient and wrong. The data are very unequal. So I build them as a ladder: at the top what is documented, at the bottom what is hypothesis.
Seven endpoints, sorted by what the data support
Vaccine response in children
Meta-analysisConsistent across several antigens, several cohorts and several countries, rated in a meta-analysis with partly high certainty. Basis of the European assessment. The effect per doubling is small.
Cholesterol in blood
large cross-sectionsVery consistent in large population and exposure cohorts. The mechanism behind it is disputed, and for a long time there was a suspicion that fat uptake in the gut pulls both values up together.
Thyroid, more precisely: TSH
Meta-analysis of observational dataAssociation with changes in TSH, without consistent effects on the free hormones. A population finding, not a diagnosis.
Birth weight
Meta-analysis of cohortsReproducible, small association, but with a known methodological weakness: in pregnancy the plasma volume changes, and that shifts concentrations independently of any effect.
Time to pregnancy
preconception cohortA strong design, because measurement took place before pregnancy. Small effect at population level. Not transferable to the individual case.
PCOS and ovary function
Animal CellMechanistically comprehensible in mouse and cell culture, at doses far above everyday human exposure. Robust human cohorts are largely missing. This is hypothesis level.
Endometriosis
systematic reviewHere the systematic review says the opposite explicitly: the hypothesis of an association with PFAS is currently not supported by data. Other environmental substances perform clearly better.
The bars are a reading aid for the strength of the data, not a risk figure. They say how certain an association is, not how large it is. Those are two different things, and they are constantly confused online.
Cholesterol: the association that pleases nobody
That higher PFAS values go along with higher cholesterol values is one of the most stable findings in this whole field. It turns up again and again in large exposure cohorts. And nobody can properly explain it.
The most obvious alternative explanation was for a long time: perhaps someone who takes up a lot of fat through the gut also takes up more PFAS at the same time, and then both values rise together without one causing the other. This assumption was tested on purpose.
In the C8 Health Project 44,126 adults from six exposed water districts were examined, 1,075 of them were taking ezetimibe, a medicine that inhibits cholesterol absorption in the gut. After adjustment for age, sex, BMI, kidney function, smoking, education and income, the PFAS levels did not differ significantly between the two groups. So this is one of the few papers that specifically looked for an obvious alternative explanation and did not find it. That makes the association more credible, but it does not explain it. Ma G, Ducatman A. Toxics. 2022;10(12):799. PMID: 36548632 · DOI: 10.3390/toxics10120799 [Cohort, cross-sectional]
Why this stands in a hormone article: cholesterol is the starting molecule for all steroid hormones. A substance that measurably shifts this metabolism therefore touches an area connected with hormone production. That a relevant hormonal change follows from this is explicitly not shown. The wider context is under cholesterol: firefighter rather than fire.
Thyroid: TSH moves, the free hormones do not
A meta-analysis with a focus on pregnancy pooled 13 studies on the association between maternal PFAS exposure and thyroid values, with a literature search up to 10 July 2022.
A positive association appeared between changes in TSH and exposure to PFOS, PFOA and PFDA. For the other thyroid hormones, that is TT3, TT4, FT3 and FT4, no significant association was found. The authors attributed the heterogeneity to sample size, region, sample type, BMI and week of pregnancy, and they explicitly recommend verification in a large cohort.
For you that means: if your TSH is borderline and nothing else fits, the environment is a legitimate thought. It is not a proof, and the free hormones do not move along in these data.
Zhang L, Liang J, Gao A. Chemosphere. 2023;315:137748. PMID: 36610509 · DOI: 10.1016/j.chemosphere.2023.137748 [Meta-analysis]The older, much cited finding on this comes from NHANES: women with PFOA in the top quartile, that is 5.7 ng/mL or more, more often reported a currently treated thyroid disease than women with 4.0 ng/mL or less, with an odds ratio of 2.24 (1.38 to 3.65). In men a similar, just not significant trend appeared for PFOA, while for PFOS there was an association in men and not in women. The authors themselves write that confounders and pharmacokinetic explanations still have to be ruled out. It is exactly this self limitation that is missing in almost every retelling.
More does not belong here. What TSH, fT3 and fT4 really mean is under thyroid values: which ones really count, and the connection to the female cycle under thyroid and female hormones. Important with this: anyone already taking a thyroid preparation does not change anything about it independently because of an environmental finding. Every adjustment belongs under medical supervision.
Birth weight and fertility
A meta-analysis pooled 21 studies on the change in birth weight per tenfold increase in maternal PFAS concentration, literature search up to 20 September 2022.
For PFOA the change was -58.62 g (-85.23 to -32.01), for PFOS -54.75 g (-84.48 to -25.02), for PFHxS -5.67 g without statistical support. In the group with a high PFOS median the association was stronger than in the group with a lower one. For a clear dose-response relationship only limited indications were found.
For you that means: around 50 to 60 grams per tenfold increase. For an individual child that is little. For a population it shifts the whole distribution a little downwards, and that is where the children sit for whom every gram counts.
Lan L, Wei H, Chen D et al. Environ Sci Pollut Res Int. 2023;30(38):89805-89822. PMID: 37458883 · DOI: 10.1007/s11356-023-28458-0 [Meta-analysis]A methodological note that is almost always missing in consumer texts: in pregnancy the plasma volume rises markedly. Women whose plasma volume increases less have higher concentrations in the blood and at the same time statistically smaller babies, without one having to have caused the other. This dilution effect tends to pull the measured associations in one direction. It does not invalidate the finding, but it probably explains part of it.
In a population based preconception cohort in Singapore, PFAS were determined in plasma in 382 women of reproductive age, measured between 2015 and 2017 before conception, with follow up over one year.
Per quartile increase there was a 5 to 10 percent lower fecundability. The fecundability ratios for a clinical pregnancy were 0.90 for PFDA (0.82 to 0.98), 0.88 for PFOS (0.79 to 0.99), 0.95 for PFOA and 0.92 for PFHpA. For PFHxS, PFNA and PFHpS no association was found.
For you that means: the design is strong because measurement took place before pregnancy. The effect is small at population level and says nothing about an individual couple trying to conceive.
Cohen NJ, Yao M, Midya V et al. Sci Total Environ. 2023;873:162267. PMID: 36801327 · DOI: 10.1016/j.scitotenv.2023.162267 [Cohort, preconception]This section is no reason to postpone a work-up. Time is a real, hard factor when trying to conceive, and nothing in these data justifies pushing back a reproductive medicine examination in order to sort out the environment first.
Both run in parallel. The gynaecological and andrological work-up remains the foundation. The environmental question comes on top of it, not in its place.
In men there is an old, small finding that is often cited large. Of 105 Danish men with a median age of 19 years, those with high combined PFOS and PFOA levels had a median of 6.2 million normally formed sperm in the ejaculate compared with 15.5 million in those with low values. For concentration, total count and the pituitary-gonadal hormones the trends remained without statistical support, and the authors themselves call for confirmation. The PFOS medians of 24.5 ng/mL at the time lie far above today's German values. Usable as an indication, not as proof. More on this under improving sperm quality.
Endometriosis: the section in which this article does not claim something
I would have liked to write something clever here about PFAS and endometriosis. It does not work, because the data do not support it.
The hypothesis is currently not supported
A systematic review following PRISMA across Scopus and PubMed screened 422 papers on environmental and occupational factors in endometriosis and included 32, of which 28 concerned chemical substances.
The result is contradictory, and the authors sort it clearly. Best supported epidemiologically is the association with organochlorine compounds. On perfluoroalkyl exposure they write explicitly that the hypothesis of an association is currently not supported by data. An involvement of metals was not confirmed. Night work over many years of service, by contrast, appeared to play a role.
In a French case-control pilot study with surgically confirmed endometriosis two other substances stood out: trans-nonachlor with an odds ratio of 3.38 (2.06 to 5.98) and PCB 114 with 1.83 (1.17 to 2.93). PFAS did not stand out in these results.
Caporossi L, Capanna S, Viganò P et al. Int J Environ Res Public Health. 2021;18(2):532. PMID: 33440623 · DOI: 10.3390/ijerph18020532 [Systematic Review] · Matta K, Lefebvre T, Vigneau E et al. Environ Int. 2021;158:106926. PMID: 34649050 · DOI: 10.1016/j.envint.2021.106926 [Case-Control Study, pilot]That is a good example of the fact that environmental toxin is not one single thing. In the same review organochlorine compounds stand out and PFAS do not. Anyone who throws everything into one pot loses exactly the information that would change something clinically.
If you have endometriosis: the diagnosis and the treatment decision belong in gynaecological hands, including the question of whether and when a laparoscopy makes sense. Nothing in this article speaks in favour of postponing an indicated operation or replacing a work-up. What an integrative view can contribute alongside is under endometriosis viewed integratively.
PCOS and ovary function: here it is hypothesis
On PCOS there is a review from 2025 describing possible effects of PFAS on the hypothalamic-pituitary-ovarian axis, on AMH, follicle maturation and gonadotropin receptor signalling. It is narrative, that is without a systematic search and without its own data. The authors describe associations between PFAS exposure and reduced fertility as well as an emerging link to PCOS, and at the same time state that the underlying molecular pathways are insufficiently understood. I cite that as a hypothesis, not as a finding.
Adult female mice received PFOS orally at a dose of 10 mg per kilogram of body weight, alongside experiments in animals without ovaries and on hypothalamic slices.
Within a week a prolonged dioestrus and fewer corpora lutea appeared, accompanied by lower progesterone, lower LH and lower hypothalamic GnRH. PFOS suppressed the oestradiol dependent increase in kisspeptin expression and prevented the LH surge. An agent that activates the kisspeptin receptor GPR54 was able to offset the cycle change again.
For you that means: this is a plausible mechanism for cycle disturbances. But it is a mouse, and the dose lies orders of magnitude above everyday human exposure. Not a single sentence that applies to you follows from this experiment.
Wang X, Bai Y, Tang C et al. Toxicol Sci. 2018;165(2):475-486. PMID: 29939337 · DOI: 10.1093/toxsci/kfy167 [In vivo, mouse]Cell study and mouse oocytes A second paper exposed mouse granulosa cells and oocytes to a mixture of PFOA, PFOS, DDE, PCB 153 and hexachlorobenzene, at exactly the concentration previously measured in human follicular fluid. The mixture disturbed steroidogenesis, less oestradiol and progesterone were released, the viability of the granulosa cells fell and in the oocytes the concentration of reactive oxygen species rose. The mechanism is comprehensible. It nonetheless remains cell culture and mouse, and it was a mixture, not PFAS alone. Krawczyk K, Marynowicz W, Pich K et al. Reprod Fertil Dev. 2023;35(3):294-305. PMID: 36403477 · DOI: 10.1071/RD21326 [In vitro, cell culture and mouse]
PCOS is a medical diagnosis with defined criteria and its own work-up. It is not made on the basis of an environmental finding and not treated on your own. The overview on this is under PCO syndrome: causes and symptoms. Anyone already taking metformin, an antiandrogen or a hormonal preparation does not change anything about that on their own because of this article.
It does not follow from this that every hormonal disturbance has an environmental cause. Environmental exposure is one level alongside sleep, blood sugar, stress, thyroid, inflammation, genetics and life phase. It stands in the row, not above it. Anyone who declares it the main cause makes the same mistake as someone who overlooks it entirely.
A comparison that makes the placement easier: zearalenone, a mould toxin, is a documented mycoestrogen. It docks directly onto the oestrogen receptor, and that is well studied. PFAS do not belong in the same category, their points of attack lie elsewhere, among others at nuclear receptors of fat metabolism. If mould is on the table for you, the article on zearalenone as a mycoestrogen is the more fitting one.
And now you know why with environmental topics I always ask first which kind of study a statement comes from.
Menopause, menstrual cycle and the reasoning error that stands almost everywhere
If you search for PFAS and menopause, within seconds you will find a headline saying, in effect: forever chemicals push women into menopause earlier.
That headline goes back to a real study. It just draws the wrong conclusion from it.
In the C8 Health Project, which arose after drinking water contamination in six water districts, 25,957 women between 18 and 65 years were analysed. Women after removal of the uterus were excluded, and adjustment was made for age, smoking, alcohol, BMI and exercise.
The odds of having already gone through menopause were increased in the highest compared with the lowest quintile: in the perimenopausal age group for PFOS and for PFOA each with an odds ratio of 1.4 (1.1 to 1.8), in the menopausal age group for PFOS with 2.1 (1.6 to 2.8) and for PFOA with 1.7 (1.3 to 2.3). Between PFOS and oestradiol an inverse association was found, and not for PFOA.
For you that means: the association is real and large. But it is a cross-section, that is a single photograph at a single point in time. And that is exactly why the second study follows now.
Knox SS, Jackson T, Javins B et al. J Clin Endocrinol Metab. 2011;96(6):1747-1753. PMID: 21411548 · DOI: 10.1210/jc.2010-2401 [Cohort, cross-sectional]Do you remember the paragraph further up? Menstruation is an elimination route.
Then think the finding through the other way round.
How pharmacokinetics turns into an apparent cause
- PFAS bind to proteins in the blood. Every period takes a small amount of them out of the body.
- A woman who still bleeds regularly loses part of her burden continuously over years in this way.
- A woman who reaches menopause earlier loses this elimination route earlier. From then on, what comes in accumulates.
- If you measure both women at 50 years, the woman with early menopause has the higher PFAS value. Not because PFAS triggered the menopause, but because the menopause ended the elimination.
- In a cross-sectional study that looks exactly like a cause. You cannot distinguish the two possibilities from a single point in time.
The same logic applies to pregnancy and breastfeeding. Both are elimination routes. Anyone who has had many children and breastfed for a long time has on average lower PFAS values, entirely without breastfeeding being a treatment.
This is not hair splitting. It has been calculated through.
A working group extended a published life stage pharmacokinetic model for PFOS and PFOA with realistic distributions of physiological parameters, including the age at menopause. Then they simulated populations built to match the real study populations.
In the simulated replication of the Knox population at ages 42 to 51 years, the odds ratio for menopause in the fifth compared with the first PFOA quintile was 1.33 (1.26 to 1.40). What had been reported was 1.4 (1.1 to 1.8). The simulated pattern arose exclusively from pharmacokinetics, not from an effect.
For you that means: a considerable part of the famous association between PFAS and early menopause can be explained solely by the fact that women after menopause no longer excrete through bleeding. That does not invalidate the data. It places them.
Ruark CD, Song G, Yoon M et al. Environ Int. 2016;99:245-254. PMID: 27927583 · DOI: 10.1016/j.envint.2016.11.030 [Mechanism, PBPK modelling]With any substance that is eliminated through blood, placenta and breast milk, a cross-sectional study with reproductive endpoints is systematically distorted. Always. In the same direction.
That does not only concern menopause. It concerns cycle length, number of children, breastfeeding duration, age at first period and everything connected with blood loss and pregnancy.
If in future you read somewhere that an environmental substance is linked to a topic in women's health, the first question is not whether the association is real. The first question is whether the endpoint itself changes elimination.
What still stands nonetheless: not everything on PFAS and reproduction is affected by this distortion. The preconception cohort from Singapore measured before pregnancy and observed afterwards. That is a longitudinal design, and there the reversal does not apply to the same degree. Birth cohorts that measure early in pregnancy and then follow the child are also more robust than a cross-section.
For you in practical terms: if your menstrual cycle is changing right now, the first question is not the environment. It is sleep, stress, thyroid, blood sugar, weight change and life phase. What actually happens in perimenopause is under perimenopause: when it begins. And if you want to know which hormone values on which cycle day carry any meaning at all, you will find that under testing hormones: which test, which timing.
Because this section deals with bleeding, menstrual cycle and menopause, here once more the note from the start of the text: bleeding after menopause, very heavy or suddenly changed bleeding, acute one-sided lower abdominal pain, pain together with fever, unintended weight loss, headaches or visual disturbances together with milk discharge, and rapidly increasing signs of virilisation belong in a timely medical examination.
This has nothing to do with PFAS. It stands here a second time because an environmental article must never be the reason to wait with something like this.
And now you know why with this topic I ask about the type of study first and only then about the result.
Measuring PFAS in blood: when that makes sense and when it does not
At some point in this article almost everyone has the same thought: can I have that measured?
Yes, technically that is possible. The question is a different one. What do you do with the result.
What the German assessment values mean
The German Human Biomonitoring Commission has set assessment values for PFAS. HBM-I is the value below which, according to current knowledge, no health impairment is expected: 2 µg/L for PFOA and 5 µg/L for PFOS in blood plasma. HBM-II lies higher and is graded by group, for women of childbearing age at 5 µg/L for PFOA and 10 µg/L for PFOS, for the rest of the population at 10 µg/L for PFOA and 20 µg/L for PFOS.
HBM-I is not a hazard threshold
- What the German Environment Agency says explicitly
- Exceeding HBM-I does not mark the point from which someone becomes ill. It marks the point from which increased precautionary efforts are appropriate: a follow-up measurement and a search for specific sources of exposure.
- How often that occurs
- In GerES V, 21.1 percent of children and adolescents were above the HBM-I value for PFOA and 7.3 percent above the one for PFOS. 0.2 percent were also above HBM-II. In two thirds of the young population at least three PFAS are detectable in blood at the same time.
- What a reference value is by contrast
- A reference value describes how exposed the population is, not from when someone becomes ill. The commission recommends the 95th percentile of the reference distribution for this. This distinction between assessment value and reference value is the most common error in interpreting environmental laboratory values.
- What is being discussed internationally
- In 2022 the American academy of sciences proposed measuring nine PFAS and combining them into a sum. A validation study on 1,023 samples found a median of this sum of 4.65 ng/mL, with 82.2 percent of samples between 2 and under 20 ng/mL. In Germany this concept is not introduced as a guideline, here the HBM values are the yardstick.
Sources: German Environment Agency, PFAS in humans, retrieved 2026-08-25 [Regulatory Document] · Hoopmann M, Murawski A, Schümann M et al. Int J Hyg Environ Health. 2023;253:114236. PMID: 37579634 · DOI: 10.1016/j.ijheh.2023.114236 [Review, methodology] · Dui W, Smith MP, Bartock SH. Anal Bioanal Chem. 2024;416(28):6333-6344. PMID: 39269501 · DOI: 10.1007/s00216-024-05519-y [Real-World, method study]
The honest limit of a measurement
I say this here as plainly as I say it in the consultation.
In Germany a PFAS blood measurement is not covered by statutory insurance. There is no guideline from a medical society recommending such a measurement for hormonal complaints in the general population. And there is no approved treatment that specifically lowers an elevated value.
That is what the reticence of routine care hangs on, and it is understandable. Almost everyone has measurable values, so a positive finding distinguishes you from nobody. And a value without an option for action can trigger worry, which is itself a health factor.
When I consider a measurement at all in my practice
- A known regional exposure. When a documented discharge or legacy site is known in the residential area and there is a concrete suspicion.
- Occupational contact. Above all fire service, airport, training grounds, certain areas of the chemical and paper industry.
- Your own well water. Here the water should be measured first anyway, not the blood. The water can be exchanged, the blood cannot.
- A pronounced, well investigated and still unexplained constellation. When the obvious causes have been cleanly ruled out and nothing fits.
- And always: only when it has been discussed beforehand what a high and what a low value would mean for the next steps. If both results lead to the same course of action, you do not need the test.
Important: I deliberately name no laboratories, no test providers and no prices here. That is not reticence out of caution but out of conviction. An environmental test belongs in a conversation, not in a shopping basket.
The more interesting question is not: how high is my value? It is: is there a source with me that can be switched off?
Because only then does searching change something. A well can be replaced. A workplace can be organised differently. A filter can be installed. A blood value alone can do none of that.
This is exactly where a functional view complements routine care without contradicting it. It asks about the source rather than the value. And it takes the time axis seriously: someone planning a pregnancy has a different reason to look than someone who has menopause behind them.
And now you know why with this topic I advise against a measurement more often than you would have expected from an integrative practice.
What you can do, and where avoidance reaches its limit
Now the part you have probably been waiting for. I am doing it honestly, even if that makes it less satisfying than the usual ten point lists.
Drinking water
Since 12 January 2026 the German drinking water ordinance has applied a combined limit of 0.1 µg/L for twenty PFAS compounds. From 12 January 2028 a markedly stricter combined limit of 0.02 µg/L for four particularly relevant compounds will be added.
The practical step is unspectacular: ask your water supplier for the current values. Most publish them or release them on request. With your own well a water analysis makes more sense than any blood measurement.
Filters, honestly considered
A critical review screened the literature on the effectiveness of point-of-use and point-of-entry filters against PFAS in tap water.
Granular activated carbon, ion exchange and reverse osmosis are used. Despite laboratory tests and certifications, performance in real operation is mostly not well characterised. Only a few peer reviewed studies actually measured PFAS after filtration at the tap, and only five assessed removal under everyday conditions. Not all filters proved effective, especially against short-chain PFAS. Improperly maintained activated carbon systems could even raise PFAS values in the treated water.
For you that means: a filter can achieve something. But the data on everyday performance are thin, short-chain compounds are the problem, and an exhausted filter can do the opposite. Maintenance is not a footnote here, it is half the benefit.
MacKeown H, Magi E, Di Carro M, Benedetti B. Sci Total Environ. 2024;954:176764. PMID: 39393709 · DOI: 10.1016/j.scitotenv.2024.176764 [Review, technical]That is why I name no models and no brands. A filter is only as good as its maintenance interval, and that depends on your consumption and your starting exposure.
Pans, air fryers and coatings
The label PFOA free means that one single, long restricted compound is no longer used. It does not mean PFAS free. That is not a deception but a correct statement about a single substance which in everyday life is read as something else.
Anyone who wants to sidestep the question cooks in stainless steel or cast iron. I would replace heavily scratched coatings, not because of a body of studies but because a broken coating has lost its purpose anyway. With the air fryer it is the same material question in a different appliance.
Baking paper and packaging
The rule of thumb that follows from the packaging analysis is simple: do not leave greasy and warm food sitting in coated paper for long. That applies to the pizza in the box just as much as to the sandwich in greaseproof paper. In the oven you can use unbleached, uncoated baking paper or a silicone baking mat. Transfer leftovers into glass or stainless steel rather than storing them in coated board.
Textiles and furniture
Impregnations on outdoor clothing, rucksacks, tents and furniture covers are a further route. In practice that does not mean clearing out the wardrobe. It means: look at the details at the next purchase and do not re-impregnate as a matter of routine.
What explicitly achieves nothing here
Juice cleanses, detox teas, alkaline powders and the usual detox weeks achieve nothing against PFAS. The reason is further up: these substances are not broken down through the liver phases but transported bound to proteins and reabsorbed. An approach aimed at phase 1 and phase 2 comes up empty here. What makes sense in detox concepts and what does not I have written down under detox done right instead of wrong.
For sauna and sweating I also found no robust data on PFAS. The idea of sweating them out is not supported. And the binders and plant based agents from the heavy metal field cannot be transferred, that is a different class of substance with a different transport route. How your body's own oestrogen is actually disposed of through the liver is under lowering oestrogen naturally through the liver.
Blood donation and bloodletting: what the study says and what it does not
An open randomised trial enrolled 285 employees and contractors of an Australian fire service with serum PFOS from 5 ng/mL, recruited between May and August 2019. Three groups of 95 each: plasma donation every six weeks, blood donation every twelve weeks, or observation only. 279 of the 285 participants were men, and the mean age was 53 years.
After twelve months PFOS fell by 2.9 ng/mL with plasma donation (-3.6 to -2.3) and by 1.1 ng/mL with blood donation (-1.5 to -0.7). In the observation group the value remained unchanged. PFHxS fell only with plasma donation, by 1.1 ng/mL. The authors write explicitly that further research is needed to assess the clinical implications of these findings.
For you that means: what was lowered is a laboratory value. Whether a disease risk falls with it is not shown. I spell out this difference deliberately, because online it almost always disappears.
Gasiorowski R, Forbes MK, Silver G et al. JAMA Netw Open. 2022;5(4):e226257. PMID: 35394514 · DOI: 10.1001/jamanetworkopen.2022.6257 [RCT, human]The open question is currently being worked on. A study protocol from Arizona describes a randomised trial with up to 1,500 active firefighters and three arms: blood and plasma donation, moderate endurance exercise, intermittent fasting. Alongside the PFAS values, cardiovascular risk profiles and epigenetic ageing are also being examined. Data collection ended in December 2025, and results were not available at the time of this research.
Donating blood makes sense for many good reasons. Not a single one of them is lowering PFAS.
Bloodletting, by contrast, is a medical procedure with its own indication and its own risks, among others for iron balance. Whether it is indicated in an individual case is a medical decision after examination and findings. On this evidence base a PFAS exposure is not a justification for it. I write this so plainly because the value falls is turning very quickly into this is a therapy. Those two sentences are not the same.
The paragraph that matters most to me
And now the uncomfortable part. There is no zero solution here.
You can swap your pan, change your baking paper and install a filter, and you will still keep measurable values. Because PFAS are in drinking water, in rain, in soil, in food, in house dust. And because what you carry inside you today comes from years you cannot undo. This is not an invitation to resignation. It is an invitation to a sense of proportion.
In my consultation I regularly see what happens when environmental worry tips over. Eating is reduced to fewer and fewer foods that count as safe. Invitations are declined because you do not know what things were cooked in. The shopping takes an hour because every package is checked. Sleep gets worse.
At that point avoidance itself has become a health problem. Chronic stress, social withdrawal and an ever narrowing diet have very well documented effects on hormones, immune system and metabolism. Considerably better documented than what this article says about PFAS and the menstrual cycle.
If you notice that control over food and packaging is starting to drive you, that is a topic of its own that deserves to be taken seriously. A good entry point is understanding eating disorders: body and mind. This is not a polite side note. It is the reason why I write environmental articles so carefully in the first place.
The realistic short list, without a claim to perfection
- Water first. Ask your supplier for the values. With your own well have the water analysed. That is the lever with the best ratio of effort to effect.
- Do not store greasy food in coated paper. Transferring into glass or stainless steel costs nothing and can be done right away.
- Decide at the next new purchase rather than throwing everything out today. Pan, rain jacket, sofa cover: the change happens when replacement is due anyway.
- Do not re-impregnate as a matter of routine. That is one of the few places where you actively add an exposure.
- And then stop. Whatever attention you have left is better invested in sleep, movement and blood sugar. For your hormones these three have a better body of studies than anything written here about PFAS.
Where the level that actually works lies
At the European Chemicals Agency a restriction procedure under REACH is running that covers the entire group of substances. As of August 2026 the Committee for Risk Assessment has completed its opinion, and the opinion of the Committee for Socio-Economic Analysis is expected by the end of 2026. Under discussion are a far reaching restriction with transition periods, sector specific derogations of five and of twelve years, each following a transition period of 18 months, and conditions for continued use. This status is in motion.
I write this without political outrage, because it is the sober description of the situation. With a substance distributed through drinking water, rain and food, it is not the shopping list that decides but regulation. That takes pressure off you. Your job is not to work on an environmental problem in your kitchen.
PFAS are a good reason to ask about the environment as well when hormonal complaints are on the table. They are not a good reason to turn your everyday life into a checklist. The best answer to a problem that is bigger than you is a calm, well informed way of dealing with it and not exhaustion through control.
And now you know why I wrote this article even though the practical recommendations in it are shorter than in almost every other text on this topic.
Frequently asked questions about PFAS and hormones
What are PFAS, in one sentence?
Per- and polyfluoroalkyl substances are a very large group of synthetic compounds in which the hydrogen on a carbon chain has been replaced by fluorine. It is precisely this carbon-fluorine bond that makes them water, grease and dirt repellent and at the same time barely degradable in biological systems. Depending on where the definition is drawn, public figures for the size of the group range from several thousand to more than ten thousand compounds.
Why are they called forever chemicals?
Because the carbon-fluorine bond is one of the strongest single bonds in organic chemistry. Neither sunlight nor soil bacteria nor the enzymes of your liver reliably get through it. In the environment PFAS therefore persist over very long periods, and in the human body over years.
How long do PFAS stay in the body?
In the Swedish cohort from Ronneby the mean estimated serum half-lives ranged from 0.94 to 5.01 years depending on the compound, 2.47 years for PFOA and 2.73 years for linear PFOS. After activated carbon filtration of the drinking water in Ohio and West Virginia the median PFOA half-life was 2.3 years. According to the German Environment Agency short-chain PFAS leave the body within a few days to about a month, while long-chain compounds take several years.
Do I have PFAS in my blood even without unusual exposure?
Very probably yes. In the population representative German survey GerES V, PFOS was quantifiable in all and PFOA in almost all of the 1,109 plasma samples examined from 3 to 17 year olds. The geometric means were 2.49 ng/mL for PFOS and 1.12 ng/mL for PFOA. A measurable value is therefore not a special case and on its own not a diagnosis.
What do HBM-I and HBM-II mean for PFAS?
HBM-I is the value below which, according to current knowledge, no health impairment is expected: 2 µg/L for PFOA and 5 µg/L for PFOS in blood plasma. The German Environment Agency states explicitly that exceeding it does not mark a hazard threshold but is a reason for a follow-up measurement and a search for sources. HBM-II lies higher and is graded by group, for women of childbearing age at 5 µg/L for PFOA and 10 µg/L for PFOS.
Is PFAS in drinking water a problem in Germany?
Since 12 January 2026 the German drinking water ordinance has applied a combined limit of 0.1 µg/L for twenty PFAS compounds, and from 12 January 2028 a combined limit of 0.02 µg/L for four particularly relevant compounds will be added. You can ask your water supplier for the current measured values. There are regional hotspots, although in a southern German study of 969 blood samples the values differed only slightly between regions with known releases and control regions.
Does a water filter help against PFAS?
In principle yes: granular activated carbon, ion exchange and reverse osmosis are regarded as suitable methods. A 2024 review notes, however, that the performance of such filters in real operation is barely characterised, that only a few peer reviewed studies actually measured PFAS after filtration at the tap, that short-chain PFAS are retained less well, and that an improperly maintained activated carbon system could even raise the values in the treated water. Maintenance is not a footnote here.
Are coated pans and air fryers dangerous?
The coating itself is a PFAS polymer that is considered largely unreactive while intact. The label PFOA free only says that one single, long restricted compound is no longer used, and says nothing about the other substances in the group. I did not find robust human data on how much actually enters the body from a scratched pan. Anyone who wants to sidestep the question cooks in stainless steel or cast iron and replaces heavily scratched coatings.
Is baking paper a PFAS problem?
Grease repellent paper can contain fluorinated compounds. In a US analysis of around 400 samples from fast food restaurants, 46 percent of the food contact papers and 20 percent of the paperboard samples contained detectable fluorine. I am not aware of a comparable German market survey. What is practical is not to leave greasy warm food sitting in coated paper for long, and to use unbleached, uncoated paper or a silicone baking mat in the oven.
Can PFAS change my thyroid values?
A meta-analysis of 13 studies with a focus on pregnancy found a positive association between PFOS, PFOA and PFDA and changes in TSH, without a consistent association with the free thyroid hormones. That is a finding at population level and not a diagnosis. An abnormal TSH value belongs first in a thyroid work-up, and the environmental question comes afterwards and replaces nothing.
Do PFAS cause an earlier menopause?
That cannot be said from the available data, and the most common error sits exactly here. A cross-sectional analysis of 25,957 women found increased odds of having already reached menopause in the highest PFAS quintile. A later modelling study reproduced a comparable pattern from pharmacokinetics alone, because women after menopause no longer excrete through their period: simulated odds ratio 1.33 versus a reported 1.4. The association is real, the direction of cause is open.
Can PFAS affect fertility?
In a preconception cohort in Singapore with 382 women there was a 5 to 10 percent lower fecundability per quartile increase, with a fecundability ratio of 0.90 for PFDA and 0.88 for PFOS. The design is strong because measurement took place before pregnancy. The effect is small at population level and says nothing about an individual couple trying to conceive. If it is not working for you, that belongs in a timely work-up, because time is a real factor when trying to conceive.
Is there a link between PFAS and endometriosis?
According to the current data, no. A systematic review following PRISMA with 32 included papers states explicitly that the hypothesis of an association with perfluoroalkyl exposure is currently not supported by data, while organochlorine compounds perform better epidemiologically. In a French case-control study trans-nonachlor and PCB 114 stood out, and PFAS did not.
Can I lower PFAS through blood donation or bloodletting?
The values fall, that has been shown. In a randomised trial with 285 Australian firefighters, PFOS fell over twelve months by 2.9 ng/mL with plasma donation every six weeks and by 1.1 ng/mL with blood donation every twelve weeks, while it remained unchanged in the observation group. The authors themselves write that further research is needed to assess the clinical implications. What was lowered is a laboratory value, not a demonstrated disease risk. Donating blood makes sense for many reasons. Bloodletting is a medical procedure with its own indication and is not performed for PFAS lowering on this evidence base.
Should I have my PFAS values measured?
In the general population I rarely see a good reason for it. In Germany there is no guideline from a medical society recommending a PFAS blood measurement for hormonal complaints, the measurement is not covered by statutory insurance, and a value without an option for action often burdens more than it helps. It looks different when a concrete source is on the table: a known regional exposure, occupational contact with firefighting foam, your own well. Then a value can carry a decision, because a source can be switched off.
What about the planned PFAS restriction in the EU?
As of August 2026 a restriction procedure under REACH is running at the European Chemicals Agency. The Committee for Risk Assessment has completed its opinion, the opinion of the Committee for Socio-Economic Analysis is expected by the end of 2026, and a decision by the Commission after that. Under discussion are a far reaching restriction with transition periods, sector specific derogations of five and of twelve years, each following a transition period of 18 months, and conditions for continued use. This status is in motion, and it is the level at which the most can change for you.
Where this topic connects to the rest of your system
PFAS do not stand alone. They are one building block in a larger question: which influences from outside end up in your hormone balance, and in what order is it worth looking.
Hormonal imbalance in women
The pillar of this cluster. It holds the whole system into which PFAS are placed as just one level.
If you want to know what else interferesXenoestrogens in everyday life
What an endocrine disruptor actually is and which groups of substances really dock onto the oestrogen receptor. PFAS are among the special cases there.
If it is about testosterone and semen qualityEndocrine disruptors in men
The same question from a male perspective, with a view to testosterone, aromatase and sperm parameters.
If your TSH is abnormalThyroid and female hormones
Why thyroid and menstrual cycle are so closely coupled. The place for everything the TSH finding from this article raises.
If you are thinking about exposure testingMeasuring heavy metals properly
The same basic question in another field: what an environmental laboratory value says and what it does not.
If mould is on the tableZearalenone as a mycoestrogen
A mould toxin that docks directly onto the oestrogen receptor. The contrast with PFAS makes both topics clearer.
If you have endometriosisEndometriosis viewed integratively
What is discussed about how it develops and what a complementary view can contribute, without replacing gynaecological treatment.
If PCOS is on the tableUnderstanding PCO syndrome
The diagnostic criteria, the role of blood sugar and why environmental factors are so far only hypothesis here.
If you are trying to conceiveImproving sperm quality
What actually carries weight in male fertility, beyond individual environmental studies from the year 2009.
If you want to understand what detoxification isLiver, phase 1 and phase 2
How your body normally converts foreign substances. And why exactly this model does not apply to PFAS.
If your cholesterol is unexplainedly highCholesterol reconsidered
The endpoint with the most stable PFAS association, embedded in the larger question of what cholesterol actually means.
If avoidance starts to drive youUnderstanding eating disorders
When control over food and packaging becomes a problem of its own. The most important link in this list.
If you want the detail on the substanceBisphenol A and your hormones
The substance from tins and till receipts, the 2023 EFSA reassessment and what BPA free does and does not mean.
If plasticisers are the questionPhthalates: the plasticisers
Why phthalates affect testosterone rather than oestrogen, and where they come from in everyday life.
If you are looking at the bathroom shelfEndocrine disruptors in cosmetics
Parabens, UV filters and fragrances, sorted by what is documented and what is merely loud.
If metals are part of the questionHeavy metals and female hormones
Cadmium as a metalloestrogen, lead and the bone store, and what blood, urine and hair analysis each show.
Scientific sources
- Schrenk D, Bignami M, Bodin L, Chipman JK et al. (EFSA Panel on Contaminants in the Food Chain). Risk to human health related to the presence of perfluoroalkyl substances in food. EFSA Journal. 2020;18(9):e06223. DOI: 10.2903/j.efsa.2020.6223 [Regulatory Document] [Guideline]
- Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):593-602. PMID: 26414233 · DOI: 10.1210/er.2015-1093 [Consensus Guideline] [Guideline]
- Hoopmann M, Murawski A, Schümann M, Göen T, Apel P, Vogel N, Kolossa-Gehring M, Röhl C. A revised concept for deriving reference values for internal exposures to chemical substances and its application to population-representative biomonitoring data in German children and adolescents 2014-2017 (GerES V). Int J Hyg Environ Health. 2023;253:114236. PMID: 37579634 · DOI: 10.1016/j.ijheh.2023.114236 [Review, methodology]
- Duffek A, Conrad A, Kolossa-Gehring M, Lange R, Rucic E, Schulte C, Wellmitz J. Per- and polyfluoroalkyl substances in blood plasma. Results of the German Environmental Survey for children and adolescents 2014-2017 (GerES V). Int J Hyg Environ Health. 2020;228:113549. PMID: 32502942 · DOI: 10.1016/j.ijheh.2020.113549 [Cohort, biomonitoring]
- Hron LMC, Wöckner M, Fuchs V, Fembacher L, Aschenbrenner B, Herr C, Schober W, Heinze S, Völkel W. Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany. Arch Toxicol. 2024;98(11):3727-3738. PMID: 39167139 · DOI: 10.1007/s00204-024-03843-x [Cohort, biomonitoring]
- Li Y, Andersson A, Xu Y, Pineda D, Nilsson CA, Lindh CH, Jakobsson K, Fletcher T. Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure. A study in Ronneby, Sweden. Environ Int. 2022;163:107198. PMID: 35447437 · DOI: 10.1016/j.envint.2022.107198 [Cohort, human]
- Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect. 2010;118(2):222-228. PMID: 20123620 · DOI: 10.1289/ehp.0901252 [Cohort, human]
- Lyu Z, Harada KH, Sugii Y, Ueda T, Kimura-Kuroda J, Nakachi S. High serum PFAS levels in a population after exposure through drinking water in western Tokyo, Japan and their half-lives estimation. Environ Health Prev Med. 2026;31:3. PMID: 41548900 · DOI: 10.1265/ehpm.25-00330 [Cohort, small, human]
- Crawford L, Halperin SA, Dzierlenga MW, Skidmore B, Linakis MW, Nakagawa S, Longnecker MP. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances. Environ Int. 2023;172:107734. PMID: 36764183 · DOI: 10.1016/j.envint.2023.107734 [Meta-analysis]
- Stein CR, McGovern KJ, Pajak AM, Maglione PJ, Wolff MS. Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey. Pediatr Res. 2016;79(2):348-357. PMID: 26492286 · DOI: 10.1038/pr.2015.213 [Cohort, cross-sectional]
- von Holst H, Nayak P, Dembek Z, Buehler S, Echeverria D, Fallacara D, John L. Perfluoroalkyl substances exposure and immunity, allergic response, infection, and asthma in children: review of epidemiologic studies. Heliyon. 2021;7(10):e08160. PMID: 34712855 · DOI: 10.1016/j.heliyon.2021.e08160 [Review, human studies]
- Zhang L, Liang J, Gao A. Contact to perfluoroalkyl substances and thyroid health effects: A meta-analysis directing on pregnancy. Chemosphere. 2023;315:137748. PMID: 36610509 · DOI: 10.1016/j.chemosphere.2023.137748 [Meta-analysis]
- Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118(5):686-692. PMID: 20089479 · DOI: 10.1289/ehp.0901584 [Cohort, cross-sectional]
- Ma G, Ducatman A. Perfluoroalkyl Substance Serum Concentrations and Cholesterol Absorption-Inhibiting Medication Ezetimibe. Toxics. 2022;10(12):799. PMID: 36548632 · DOI: 10.3390/toxics10120799 [Cohort, cross-sectional]
- Cohen NJ, Yao M, Midya V, India-Aldana S, Mouzica T, Andra SS, Narasimhan S, Meher AK, Arora M, Chan JKY, Chan SY, Loy SL, Minguez-Alarcon L, Oulhote Y, Huang J, Valvi D. Exposure to perfluoroalkyl substances and women's fertility outcomes in a Singaporean population-based preconception cohort. Sci Total Environ. 2023;873:162267. PMID: 36801327 · DOI: 10.1016/j.scitotenv.2023.162267 [Cohort, preconception]
- Lan L, Wei H, Chen D, Pang L, Xu Y, Tang Q, Li J, Xu Q, Li H, Lu C, Wu W. Associations between maternal exposure to perfluoroalkylated substances (PFASs) and infant birth weight: a meta-analysis. Environ Sci Pollut Res Int. 2023;30(38):89805-89822. PMID: 37458883 · DOI: 10.1007/s11356-023-28458-0 [Meta-analysis]
- Knox SS, Jackson T, Javins B, Frisbee SJ, Shankar A, Ducatman AM. Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011;96(6):1747-1753. PMID: 21411548 · DOI: 10.1210/jc.2010-2401 [Cohort, cross-sectional]
- Ruark CD, Song G, Yoon M, Verner MA, Andersen ME, Clewell HJ, Longnecker MP. Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause. Environ Int. 2016;99:245-254. PMID: 27927583 · DOI: 10.1016/j.envint.2016.11.030 [Mechanism, PBPK modelling]
- Caporossi L, Capanna S, Viganò P, Alteri A, Papaleo B. From Environmental to Possible Occupational Exposure to Risk Factors: What Role Do They Play in the Etiology of Endometriosis? Int J Environ Res Public Health. 2021;18(2):532. PMID: 33440623 · DOI: 10.3390/ijerph18020532 [Systematic Review]
- Matta K, Lefebvre T, Vigneau E, Cariou V, Marchand P, Guitton Y, Royer AL, Ploteau S, Le Bizec B, Antignac JP, Cano-Sancho G. Associations between persistent organic pollutants and endometriosis: A multiblock approach integrating metabolic and cytokine profiling. Environ Int. 2021;158:106926. PMID: 34649050 · DOI: 10.1016/j.envint.2021.106926 [Case-Control Study, pilot]
- Joensen UN, Bossi R, Leffers H, Jensen AA, Skakkebaek NE, Jørgensen N. Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect. 2009;117(6):923-927. PMID: 19590684 · DOI: 10.1289/ehp.0800517 [Cohort, cross-sectional]
- Voros C, Athanasiou D, Papapanagiotou I, Mavrogianni D, Varthaliti A, Bananis K et al. Molecular Shadows of Per- and Polyfluoroalkyl Substances (PFASs): Unveiling the Impact of Perfluoroalkyl Substances on Ovarian Function, Polycystic Ovarian Syndrome (PCOS), and In Vitro Fertilization (IVF) Outcomes. Int J Mol Sci. 2025;26(14):6604. PMID: 40724853 · DOI: 10.3390/ijms26146604 [Mechanism Review, narrative]
- Wang X, Bai Y, Tang C, Cao X, Chang F, Chen L. Impact of Perfluorooctane Sulfonate on Reproductive Ability of Female Mice through Suppression of Estrogen Receptor alpha-Activated Kisspeptin Neurons. Toxicol Sci. 2018;165(2):475-486. PMID: 29939337 · DOI: 10.1093/toxsci/kfy167 [In vivo, mouse]
- Krawczyk K, Marynowicz W, Pich K, Jedruch O, Kania G, Gogola-Mruk J, Tworzydlo W, Polanski Z, Ptak A. Persistent organic pollutants affect steroidogenic and apoptotic activities in granulosa cells and reactive oxygen species concentrations in oocytes in the mouse. Reprod Fertil Dev. 2023;35(3):294-305. PMID: 36403477 · DOI: 10.1071/RD21326 [In vitro, cell culture and mouse]
- Schaider LA, Balan SA, Blum A, Andrews DQ, Strynar MJ, Dickinson ME, Lunderberg DM, Lang JR, Peaslee GF. Fluorinated Compounds in U.S. Fast Food Packaging. Environ Sci Technol Lett. 2017;4(3):105-111. PMID: 30148183 · DOI: 10.1021/acs.estlett.6b00435 [Real-World, product analysis]
- MacKeown H, Magi E, Di Carro M, Benedetti B. Removal of perfluoroalkyl and polyfluoroalkyl substances from tap water by means of point-of-use treatment: A review. Sci Total Environ. 2024;954:176764. PMID: 39393709 · DOI: 10.1016/j.scitotenv.2024.176764 [Review, technical]
- Gasiorowski R, Forbes MK, Silver G, Krastev Y, Hamdorf B, Lewis B, Tisbury M, Cole-Sinclair M, Lanphear BP, Klein RA, Holmes N, Taylor MP. Effect of Plasma and Blood Donations on Levels of Perfluoroalkyl and Polyfluoroalkyl Substances in Firefighters in Australia: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(4):e226257. PMID: 35394514 · DOI: 10.1001/jamanetworkopen.2022.6257 [RCT, human]
- Conner R, Porter C, Lutrick K, Beitel SC, Hollister J, Healy O, Kern KJ, Wardenaar F, Gulotta JJ, Jack K, Huentelman M, Burgess JL, Furlong M. Interventions to Reduce Serum Per- and Poly-Fluoroalkyl Substances Levels, Improve Cardiovascular Risk Profiles, and Improve Epigenetic Age Acceleration in US Firefighters: Protocol for Randomized Controlled Trial. JMIR Res Protoc. 2025;14:e67120. PMID: 40239196 · DOI: 10.2196/67120 · ClinicalTrials.gov NCT05869747 [RCT, study protocol, ongoing]
- Dui W, Smith MP, Bartock SH. Development, validation, and clinical assessment of a liquid chromatography-tandem mass spectrometry serum assay for per- and polyfluoroalkyl substances (PFAS) recommended by the National Academies of Science, Engineering, and Medicine (NASEM). Anal Bioanal Chem. 2024;416(28):6333-6344. PMID: 39269501 · DOI: 10.1007/s00216-024-05519-y [Real-World, method study]
- German Environment Agency (Umweltbundesamt). PFAS in humans: HBM-I and HBM-II values, results from GerES V, half-lives. Retrieved 25 August 2026. No DOI, PMID: not applicable. [Regulatory Document] [Guideline]
- European Food Safety Authority (EFSA). Topic page Per- and polyfluoroalkyl substances (PFAS): TWI 4.4 ng/kg body weight per week, vaccine response as the critical endpoint, fish meat, fruit and fruit products and eggs and egg products as the main contributing food groups. Retrieved 25 August 2026. No DOI, PMID: not applicable. [Regulatory Document]
- German Drinking Water Ordinance (Trinkwasserverordnung), as of 2026. Combined limit PFAS-20 of 0.1 µg/L since 12 January 2026, combined limit PFAS-4 of 0.02 µg/L from 12 January 2028. No DOI, PMID: not applicable. [Regulatory Document]
- European Chemicals Agency (ECHA). PFAS restriction procedure under REACH, procedural status August 2026: opinion of the Committee for Risk Assessment completed, opinion of the Committee for Socio-Economic Analysis expected by the end of 2026. Retrieved 25 August 2026. No DOI, PMID: not applicable. [Regulatory Document]
- National Academies of Sciences, Engineering, and Medicine (NASEM). Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington DC, 2022. Recommendation to measure nine PFAS in serum or plasma and to sum them. Not introduced as a guideline in Germany. No DOI, PMID: not applicable. [Consensus Guideline] [Guideline]
- PFAS and PCOS. On this there is essentially one narrative review without a systematic search and without its own data. I did not find robust human cohorts. That is hypothesis level and is named as such explicitly here.
- PFAS and endometriosis. The systematic review does not say unclear, it says currently not supported by data. A text that hints at an association here goes beyond its sources.
- PFAS and early menopause. The association is real, the direction of causation is open and largely explainable pharmacokinetically. From a cross-section that cannot be resolved.
- PFAS and sperm quality. A cross-sectional study from 2009 with 105 young men, at PFOS values markedly higher than today, without confirmation in a larger paper. Small, old, unconfirmed.
- Cycle disturbances in the mechanism. The findings on kisspeptin and prolonged dioestrus come from the mouse at 10 mg/kg body weight, the steroidogenesis findings from cell culture with a mixture of substances. Both are explicitly marked as animal and cell data and carry no statement about humans.
- Thyroid. In the meta-analysis TSH shifts, the free hormones do not move along. The older NHANES finding is qualified by the authors themselves with a reference to confounders and pharmacokinetic explanations.
- Birth weight. The association is reproducible and small. The change in plasma volume during pregnancy is a known source of bias that could explain part of the effect.
- Bloodletting and blood donation. What was lowered is a laboratory value. A clinical benefit is not shown, the authors write that themselves, and the follow-up study is still running. This is not a therapy.
- Water filters. Methods that work in principle, but very thin data on everyday performance, poorer retention of short-chain PFAS and a real risk with exhausted activated carbon filters.
- Regional exposure as a risk marker. In the southern German study, exposed regions and control regions barely differed. Place of residence is therefore not suitable as a screening criterion.
- Non-stick coatings. On the question of how much is actually taken up from scratched pans I found no robust human study. The particle numbers in circulation come from work on microplastics and not on PFAS.
- Trifluoroacetic acid (TFA). Much discussed at present, but I did not find a robust data base on hormonal or reproductive endpoints in this research. That is why no statement about it stands here.
- Size of the group of substances. The circulating figures depend on where the definition is drawn. I give a range instead of a fixed number, because I cannot document the fixed number.
- Regulatory positions are in motion. The status of the ECHA procedure is dated August 2026 and will change.
- What deliberately does not stand here. No product recommendation, no brand, no filter model, no laboratory, no source of supply, no dosage and no protocol. No advice to change, reduce or stop an existing medication, neither the pill nor hormone replacement therapy, metformin, antiandrogens, GnRH analogues or thyroid hormones. Every adjustment belongs under medical supervision. And from no section does it follow that a gynaecological work-up, a reproductive medicine examination or an indicated operation should be postponed.